BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.57
+0.18 (2.44%)
At close: Dec 20, 2024, 4:00 PM
7.63
+0.06 (0.79%)
After-hours: Dec 20, 2024, 6:00 PM EST
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$15.60
Upside
+106.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +32.10% | Nov 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +84.94% | Nov 5, 2024 |
| Barclays | Barclays | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +5.68% | Nov 5, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +111.36% | Aug 6, 2024 |
| Barclays | Barclays | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | -7.53% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +32.10% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +296.30% | Aug 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +58.52% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +296.30% | May 7, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +98.15% | May 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +58.52% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +58.52% | Jan 8, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $10 | Buy | Initiates | $10 | +32.10% | Nov 20, 2023 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +58.52% | Nov 6, 2023 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +32.10% | Sep 25, 2023 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $9 → $10 | Hold → Buy | Upgrades | $9 → $10 | +32.10% | Sep 18, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.